.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
QuintilesIMS
Merck
UBS
Farmers Insurance
Medtronic
Moodys
US Department of Justice
Cantor Fitzgerald
Citi

Generated: December 17, 2017

DrugPatentWatch Database Preview

LUVOX Drug Profile

« Back to Dashboard

Which patents cover Luvox, and what generic alternatives are available?

Luvox is a drug marketed by Ani Pharms, Solvay, and Jazz Pharms. and is included in three NDAs. There is one patent protecting this drug and two Paragraph IV challenges.

The generic ingredient in LUVOX is fluvoxamine maleate. There are eleven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the fluvoxamine maleate profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani PharmsLUVOXfluvoxamine maleateTABLET;ORAL021519-001Dec 20, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
SolvayLUVOXfluvoxamine maleateTABLET;ORAL020243-004Dec 5, 1994DISCNYesNo► Subscribe► Subscribe► Subscribe
SolvayLUVOXfluvoxamine maleateTABLET;ORAL020243-001Dec 5, 1994DISCNYesNo► Subscribe► Subscribe► Subscribe
Jazz PharmsLUVOX CRfluvoxamine maleateCAPSULE, EXTENDED RELEASE;ORAL022033-001Feb 28, 2008DISCNYesNo► Subscribe► SubscribeY► Subscribe
Ani PharmsLUVOXfluvoxamine maleateTABLET;ORAL021519-002Dec 20, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Ani PharmsLUVOXfluvoxamine maleateTABLET;ORAL021519-003Dec 20, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
SolvayLUVOXfluvoxamine maleateTABLET;ORAL020243-003Dec 5, 1994DISCNYesNo► Subscribe► Subscribe► Subscribe
SolvayLUVOXfluvoxamine maleateTABLET;ORAL020243-002Dec 5, 1994DISCNYesNo► Subscribe► Subscribe► Subscribe
Jazz PharmsLUVOX CRfluvoxamine maleateCAPSULE, EXTENDED RELEASE;ORAL022033-002Feb 28, 2008DISCNYesNo► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: LUVOX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
SolvayLUVOXfluvoxamine maleateTABLET;ORAL020243-001Dec 5, 1994► Subscribe► Subscribe
SolvayLUVOXfluvoxamine maleateTABLET;ORAL020243-004Dec 5, 1994► Subscribe► Subscribe
SolvayLUVOXfluvoxamine maleateTABLET;ORAL020243-003Dec 5, 1994► Subscribe► Subscribe
SolvayLUVOXfluvoxamine maleateTABLET;ORAL020243-002Dec 5, 1994► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for LUVOX

Drugname Dosage Strength RLD Submissiondate
fluvoxamine maleateExtended-release Capsules100 mgLuvox CR4/20/2009
fluvoxamine maleateExtended-release150 mgLuvox CR4/13/2009

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Argus Health
Accenture
Mallinckrodt
Harvard Business School
Covington
AstraZeneca
Chubb
Fish and Richardson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot